MALDI-TOF MS analysis of urinary nucleosides (Q33215515)

24 July 2017

MALDI-TOF MS analysis of urinary nucleosides (English)

1 reference

matrix-assisted laser desorption/ionization

24 July 2017

0 references

author name string

Bernd Kammerer

1

1 reference

24 July 2017

Antje Frickenschmidt

2

1 reference

24 July 2017

Christoph H Gleiter

3

1 reference

24 July 2017

Stefan Laufer

4

1 reference

24 July 2017

Hartmut Liebich

5

1 reference

24 July 2017

20 April 2005

1 reference

Journal of the American Society for Mass Spectrometry

24 July 2017

1 reference

24 July 2017

16

1 reference

24 July 2017

6

1 reference

24 July 2017

940-947

1 reference

https://scigraph.springernature.com/pub.10.1016/j.jasms.2005.02.018

24 July 2017

0 references

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Transfer RNA modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Summary: the modified nucleosides of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Analysis of urinary nucleosides. III. Identification of 5'-deoxycytidine in urine of a patient with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Prognostic molecular markers in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Breast carcinoma. Biological principles, classification and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Relationship of urinary pseudouridine and l-methyladenosine to activity of leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Quantitation of urinary nucleosides by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Small molecule analysis by MALDI mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Ultraviolet/matrix-assisted laser desorption/ionization mass spectrometric characterization of 2,5-dihydroxybenzoic acid-induced reductive hydrogenation of oligonucleotides on cytosine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Isolation and characterization of 1-β--ribofuranosylpyridin-4-one-3-carboxamide from human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Occurrence of N2,N2,7-Trimethylguanosine in Minor RNA Species of a Mammalian Cell Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2005.02.018

Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine

21 January 2018

1 reference

12 December 2020

tRNA breakdown products as markers for cancer

1 reference

12 December 2020

Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/electrospray mass spectrometry

1 reference

12 December 2020

Chemical ionization mass spectrometry of nucleosides. Mechanisms of ion formation and estimations of proton affinity

1 reference

12 December 2020

High turnover rate of transfer RNA in tumor tissue

1 reference

12 December 2020

Fast atom bombardment combined with tandem mass spectrometry for the determination of nucleosides

1 reference

12 December 2020

Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung

1 reference

12 December 2020

N-Methyl-4-pyridone-5-carboxamide as a metabolite of nicotinic acid in man and monkey

1 reference

12 December 2020

Modified nucleosides in urine: selective removal and analysis

1 reference

12 December 2020

Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients

1 reference

12 December 2020

Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients

1 reference

12 December 2020

Ribonucleoside analysis by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

10.1016/J.JASMS.2005.02.018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference